Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use

Disclosed are quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined in the specification. The compounds are useful as non-competitive metabotropic glutamate receptor 2 (mGluR2) antagonists, or mGluR2 negative allosteric mo...

Full description

Saved in:
Bibliographic Details
Main Authors BUNGARD CHRISTOPHER JAMES, MENG ZHAOYANG, MANLEY PETER J, DE LEON PABLO, MANIKOWSKI JESSE JOSEF, MEISSNER ROBERT, PERKINS JAMES J, SHU YOUHENG, RUDD MICHAEL T, CONVERSO ANTONELLA, HARTINGH TIMOTHY JOHN, HANNEY BARBARA
Format Patent
LanguageEnglish
Published 28.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined in the specification. The compounds are useful as non-competitive metabotropic glutamate receptor 2 (mGluR2) antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating diseases or disorders in which the mGluR2-NAM receptor is involved, such as Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders. Examples of a compound of formula (I) are: 4-(4-fluorophenyl)-7-((3-methyl-2,5-dioxoimidazolidin-1-yl)methyl)quinoline-2-carboxamide 7-[(2,5-dioxopyrrolidin-1-yl)methyl]-4-(4-methoxyphenyl)quinoline-2-carboxamide Ethyl-1-{ [2-carbamoyl-4-(4-fluorophenyl)quinolin-7-yl]methyl} -3-(trifluoromethyl)-1H-pyrazole-4-carboxylate 7-[(4,4-dimethyl-2,6-dioxopiperidin-1-yl)methyl]-4-(4-fluorophenyl)quinoline-2-carbonitrile
Bibliography:Application Number: NZ20120624596